BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 12962527)

  • 21. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
    Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
    Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome.
    Post MJ; Thurnher MM; Clifford DB; Nath A; Gonzalez RG; Gupta RK; Post KK
    AJNR Am J Neuroradiol; 2013 Jul; 34(7):1297-307. PubMed ID: 22790246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome].
    Braicks O; Anneken K; Reichelt D; Schäbitz WR; Dziewas R; Evers S; Husstedt IW
    Nervenarzt; 2011 Oct; 82(10):1290-5. PubMed ID: 21567297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aids-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in São Paulo, Brazil.
    Vidal JE; Penalva de Oliveira AC; Fink MC; Pannuti CS; Trujillo JR
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):209-12. PubMed ID: 18813759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brain involvement in acquired immunodeficiency syndrome (AIDS): computed tomography (CT) and magnetic resonance tomography (MR)].
    Krestin GP; Jürgens R; Steinbrich W; Diederich N
    Rofo; 1986 Dec; 145(6):625-30. PubMed ID: 3025945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.
    Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E
    Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Central nervous system infections in HIV patients in the era of high activity antiretroviral treatment].
    Rivas González P; Fernández Guerrero ML
    Rev Clin Esp; 2005 Jun; 205(6):278-82. PubMed ID: 15970136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal neurological disease in patients with acquired immunodeficiency syndrome.
    Skiest DJ
    Clin Infect Dis; 2002 Jan; 34(1):103-15. PubMed ID: 11731953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
    Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
    J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurologic opportunistic infections.
    Clifford DB
    Curr Opin Neurol; 1995 Jun; 8(3):175-8. PubMed ID: 7551115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the diagnosis and treatment of infections caused by herpesvirus and JC virus].
    Arribas JR; Arrizabalaga J; Mallolas J; López-Cortés LF
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():11-9. PubMed ID: 9859615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical features of PML.
    Berger JR
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S8-12. PubMed ID: 22123935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of aids related PML with HAART and cidofovir.
    Zimmermann T; Stingele K; Hartmann M; Haas J; von Einsiedel R; Wildemann B
    Eur J Med Res; 2001 May; 6(5):190-62. PubMed ID: 11410399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurologic conditions are difficult to treat.
    van Baelen G
    GMHC Treat Issues; 1995 Mar; 9(3):8-11. PubMed ID: 11362362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryptococcosis.
    White MH; Armstrong D
    Infect Dis Clin North Am; 1994 Jun; 8(2):383-98. PubMed ID: 8089466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-associated PML: changing epidemiology and clinical approach.
    Simpson DM
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S24-7. PubMed ID: 22123930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changing pattern of HIV neuropathology in the HAART era.
    Gray F; Chrétien F; Vallat-Decouvelaere AV; Scaravilli F
    J Neuropathol Exp Neurol; 2003 May; 62(5):429-40. PubMed ID: 12769183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ophthalmologic manifestations of acquired immune deficiency syndrome-associated progressive multifocal leukoencephalopathy.
    Ormerod LD; Rhodes RH; Gross SA; Crane LR; Houchin KW
    Ophthalmology; 1996 Jun; 103(6):899-906. PubMed ID: 8643245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV disorders of the brain: pathology and pathogenesis.
    Del Valle L; Piña-Oviedo S
    Front Biosci; 2006 Jan; 11():718-32. PubMed ID: 16146764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.